Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease

Published:2023-12-07 Issue: Volume: Page:
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Behari Jaideep^ORCID,Bradley Allison,Townsend Kevin,Becich Michael J.,Cappella Nickie,Chuang Cynthia H.,Fernandez Soledad A.,Ford Daniel E.,Kirchner H. Lester,Morgan Richard,Paranjape Anuradha,Silverstein Jonathan C.,Williams David A.,Donahoo W. Troy,Asrani Sumeet K.,Ntanios Fady,Ateya Mohammad,Hegeman-Dingle Rozelle,McLeod Euan,McTigue Kathleen

Funder

Pfizer

Patient-Centered Outcomes Research Institute

National Cancer Institute

National Center for Advancing Translational Sciences

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-023-08186-8.pdf

Reference44 articles.

1. Lazarus JV, Mark HE, Anstee QM et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19:60–78.

2. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686–690.

3. Chalasani N, Younossi Z, Lavine JE et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–357.

4. Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70:962–969.

5. Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J Hepatol. 2016;65:589–600.